Shrita M. Patel

Statistics

Publications

Citations

331

H-Index

Active since

2009

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Pfizer (United States)

University of Pennsylvania

Shrita M. Patel is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacotherapy, diabetes mellitus, and diabetes pharmacotherapy.

Publications per year

2009–2023

Publications

Higher Serum Testosterone Concentration in Older Women is Associated with Insulin Resistance, Metabolic Syndrome, and Cardiovascular Disease

Shrita M. Patel, Sarah J. Ratcliffe, Muredach P. Reilly et al. · The Journal of Clinical Endocrinology & Metabolism · 2009 · 130 citations · Full text

Medicine, Endocrinology, Geriatric Medicine +17

The Importance of Whole Body Imaging in Tumor-Induced Osteomalacia

William H Chong, Sahzene Yavuz, Shrita M. Patel et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 48 citations · Full text

Medicine, Oncology, Radiology +15

Effects of ertugliflozin on renal function over 104 weeks of treatment: a post hoc analysis of two randomised controlled trials

David Z.I. Cherney, Hiddo J.L. Heerspink, Robert Frederich et al. · Diabetologia · 2020 · 42 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

SGLT2 Inhibitors and the Risk of Hospitalization for Fournier’s Gangrene: A Nested Case–Control Study

Tongtong Wang, Shrita M. Patel, Anne Hickman et al. · Diabetes Therapy · 2020 · 30 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Safety of Ertugliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Seven Phase 3 Randomized Controlled Trials

Shrita M. Patel, Anne Hickman, Robert Frederich et al. · Diabetes Therapy · 2020 · 23 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

1–5 of 9